Tag: Novo Nordisk A/S
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the "frenzy" of weight loss drugs,...
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
North Carolina's Research Triangle is one of the fastest-growing areas in the U.S., with a population that's boomed by 5.6% since 2020 to...
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024.Scott Olson | Getty...
JPMorgan says this new player in the GLP-1 market could rally 45%
JPMorgan thinks Viking Therapeutics could be the next big name in the GLP-1 boom. The firm initiated coverage of the biopharmaceutical company with...
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Weight loss syringes of the brands "Wegovy", "Ozempic" and "Mounjaro" are sold at In der Achat Apotheke in Mitte, Germany.Picture Alliance | Picture...
Weight loss drugs cut Covid-19 deaths, study finds
People taking the key component of blockbuster weight loss drugs Ozempic and Wegovy were less likely to die of Covid-19 or suffer adverse...